Preventative Screenings for Women

Preventative medicine is the bedrock of female longevity. Shifting from reactive treatments to proactive surveillance drastically reduces mortality rates, but navigating the changing guidelines for clinical screenings can be confusing.

Cervical Cancer Surveillance

The integration of HPV (Human Papillomavirus) testing has revolutionized cervical cancer prevention. Current ACOG guidelines recommend Pap smears begin at age 21. For women aged 30 to 65, co-testing (Pap smear + HPV test) every five years is the gold standard, as persistent high-risk HPV strains are the primary driver of cervical dysplasia.

Mammography Guidelines

While general guidelines recommend annual mammograms starting at age 40, clinical nuance is required. Women with dense breast tissue—which masks tumors on standard x-rays—may require adjunct 3D mammography (tomosynthesis) or breast ultrasounds. Those with a first-degree relative with pre-menopausal breast cancer or BRCA1/2 mutations should begin screening 10 years prior to their relative's age of diagnosis.

Bone Mineral Density (DEXA)

Osteoporosis is a silent disease until a catastrophic fracture occurs. The sudden drop in estrogen during menopause rapidly accelerates bone resorption. A baseline DEXA scan is universally recommended at age 65, but women with clinical risk factors (history of corticosteroid use, smoking, or low body weight) should request scans immediately post-menopause.